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Limiting replication stress during somatic cell
reprogramming reduces genomic instability in
induced pluripotent stem cells
Sergio Ruiz1, Andres J. Lopez-Contreras1,w, Mathieu Gabut2,3,w, Rosa M. Marion4, Paula Gutierrez-Martinez1,
Sabela Bua5, Oscar Ramirez6, In˜igo Olalde6, Sara Rodrigo-Perez1, Han Li5, Tomas Marques-Bonet6,7,
Manuel Serrano8, Maria A. Blasco4, Nizar N. Batada2,3 & Oscar Fernandez-Capetillo1
The generation of induced pluripotent stem cells (iPSC) from adult somatic cells is one of the
most remarkable discoveries in recent decades. However, several works have reported
evidence of genomic instability in iPSC, raising concerns on their biomedical use. The reasons
behind the genomic instability observed in iPSC remain mostly unknown. Here we show that,
similar to the phenomenon of oncogene-induced replication stress, the expression of
reprogramming factors induces replication stress. Increasing the levels of the checkpoint
kinase 1 (CHK1) reduces reprogramming-induced replication stress and increases the efﬁ-
ciency of iPSC generation. Similarly, nucleoside supplementation during reprogramming
reduces the load of DNA damage and genomic rearrangements on iPSC. Our data reveal that
lowering replication stress during reprogramming, genetically or chemically, provides a simple
strategy to reduce genomic instability on mouse and human iPSC.
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R
eprogramming of somatic cells into induce pluripotent
stem cells (iPSC) can be achieved by the expression
of deﬁned sets of transcription factors1 (for example,
OCT4, SOX2, KLF4 and cMYC; OSKM hereafter). However,
recent reports have shown evidence of DNA damage
and genomic instability in iPSC2–8, raising concerns on
their potential biomedical use. The source of genomic
instability on iPSC remains unresolved, although several
evidence suggest that it could be linked to replication stress
(RS), a type of DNA damage occurring at stalled replication forks
and limited by the ataxia telangiectasia and Rad3-related (ATR)
and checkpoint kinase 1 (CHK1) kinases9. While the causes of
RS are still not fully understood, some of the sources
include insufﬁcient levels of deoxynucleotides10, reduced levels
of replication factors11, or mutations in DNA repair and
replication factors (reviewed in ref. 9).
According to the oncogene-induced DNA damage model of
cancer development, the expression of oncogenes leads to
genomic instability in cancer cells through the generation of
RS12. Interestingly, and besides the well-established role of
cMYC, the remaining three factors of the OSKM set have also
been shown to play oncogenic roles13–15. Hence, we hypothesized
that similar to oncogene-induced RS; an analogous
reprogramming-induced RS could drive genomic instability in
iPSC. Supporting this view, we and others have recently
demonstrated that iPSC contain genomic structural variations
such as copy number variants (CNV) that were highly enriched in
fragile sites3,7,8, a hallmark of RS. Furthermore, mouse embryonic
ﬁbroblasts (MEF) with reduced levels of ATR and which
are highly sensitive to RS and resistant to transformation by
oncogenes16,17, are also refractory to reprogramming (our own
observations). In this work, we provide evidence for RS occurring
at the reprogramming process and to understand the mechanisms
underlying this RS. If RS were to signiﬁcantly contribute to the
genomic rearrangements found in iPSC, we reasoned that
strategies directed to lowering reprogramming-induced RS
could offer a strategy to reduce genomic instability on iPSC.
Results
The expression of reprogramming factors generates RS. First,
we evaluated to what extent DNA damage occurred during
reprogramming by analysing the levels of H2AX phosphorylation
(gH2AX). High-throughput microscopy (HTM) and western blot
analyses revealed increased levels of gH2AX in MEF (Fig. 1a,b;
Supplementary Fig. 1) and human ﬁbroblasts (Fig. 1c,d;
Supplementary Fig. 2) expressing OSK, when compared with green
ﬂuorescent protein (GFP)-expressing cells or uninfected control
cells. Furthermore, these levels were further augmented in the
presence of cMYC. To discard the impact of viral integration,
which could cause DNA breaks and induce gH2AX, we used a
previously reported ﬁbroblast-like human cell line, which expresses
OSK in response to doxycycline18 (dFib-indOSK) (Supplementary
Fig. 3a). The expression of OSK in these cells induced gH2AX in a
dose-dependent manner, which could again be further potentiated
by the inclusion of cMYC (Supplementary Fig. 3b–e). Next, as
direct measure of RS, we observed that replication fork speed,
measured by single molecule DNA combing analysis, is lower in
cells expressing OSKM than in GFP-expressing cells
(Supplementary Fig. 3f). Interestingly, fork symmetry was not
altered in OSKM-expressing ﬁbroblasts when compared with GFP
control cells (ratio of short to long tracks: GFP¼ 0.7429±0.178,
OSKM¼ 0.7341±0.1867; P¼ 0.96). Finally, since cells suffering
from RS are particularly dependent on RS-response kinases17,19,20,
we tested the effect of lowering ATR and CHK1 activity during
reprogramming. Addition of ATR or CHK1 inhibitors interfered
with the successful generation of iPSC colonies in a dose-
dependent manner (Supplementary Fig. 4). Collectively, these
data demonstrate that expression of reprogramming factors
induces RS.
Strategies to reduce reprogramming-induced RS. RS-generating
oncogenes frequently upregulate CHK1 as a way to limit trans-
formation-associated RS21–23. Similarly, OSK expression in
human ﬁbroblasts increases CHK1 levels (Supplementary
Fig. 5). Importantly, cMYC was excluded from the
reprogramming cocktail since it transcriptionally induces CHK1
expression21. We recently reported the generation of mice
selectively protected against RS, which harbour one additional
allele of the Chk1 gene24 (Chk1TG). In agreement with the idea
that oncogenes upregulate CHK1 to limit RS24, Chk1TG MEF
present lower levels of oncogene-induced RS and transform more
efﬁciently than wild-type (wt) cells with Ras and E1A
oncogenes24. Similarly, Chk1TG MEF presented lower levels of
reprogramming-induced gH2AX (Fig. 2a). Thus, given our
previous observations on oncogene-induced RS, we
hypothesized that Chk1TG MEF could reprogramme more
efﬁciently than wt cells. In fact, we observed an increase in the
reprogramming efﬁciency of Chk1TG cells, which was more
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Figure 1 | Expression of reprogramming factors generates replication
stress. (a,c) HTM-mediated quantiﬁcation of gH2AX intensity levels in
MEFs (a) or BJ human ﬁbroblasts (c) 4 days after infection with
retroviruses encoding GFP, OSK or OSKM. Uninfected cells (struck through
circle) were also included as negative control. Centre lines indicate mean
values, whereas squared boxes show the percentage of outliers. Data are
representative of three independent experiments performed in triplicate
***Po0.001. (b,d) Western blot analyses of cell extracts obtained from
MEFs (b) or BJ human ﬁbroblasts (d) 4 days after infection with
retroviruses encoding GFP, OSK or OSKM. Uninfected cells (struck through
circle), human (BJ or PGP2-derived iPSC lines) or mouse iPSCs were also
included as controls. See Supplementary Fig. 14 for full western blot images.
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pronounced on Chk1TG/TG than on Chk1TG/þ MEF (Fig. 2b,c;
Supplementary Fig. 6). Consistent with MEF data, overexpression
of CHK1 also reduced OSK-induced gH2AX levels in human
ﬁbroblasts (Supplementary Fig. 7a). In addition, increased CHK1
levels boosted reprogramming efﬁciencies on the inducible
human dFib-indOSK system (Supplementary Fig. 7b). This effect
was also noticeable even in the presence of high doses of
doxycycline, which implies a higher expression of reprogramming
factors, higher RS-driven toxicity and, as a consequence, lower
reprogramming efﬁciencies. When cMYC was introduced in the
cocktail, expression of CHK1 increased reprogramming efﬁciency
speciﬁcally at high doses of doxycycline (Supplementary Fig. 7c).
Altogether, these data reveal that reprogramming factors induce
RS and upregulate CHK1 in an attempt to prevent replicative
damage. In this context, increasing CHK1 levels confers an
additional protection from reprogramming-induced RS and
increases the efﬁciency of iPSC generation.
We next explored whether we could reduce reprogramming-
induced RS by chemical means, without the need to add another
vector to the reprogramming cocktail. While nucleotides are not
cell-permeable, nucleoside supplementation has been shown to
limit oncogene-induced RS10. Likewise, reprogramming-induced
gH2AX levels were progressively lowered by increasing amounts
of nucleosides (Fig. 3a; Supplementary Figs 8a and 9).
Furthermore, this effect was independent of cMYC expression
(Fig. 3a; Supplementary Figs 8b and 9). Moreover, nucleoside
supplementation was also able to rescue the reduced fork speed
observed after expression of reprogramming factors (Fig. 3b). Of
note, and in contrast to CHK1, nucleosides suppressed
reprogramming-induced RS but did not increase reprogramming
efﬁciencies (Fig. 3c,d; Supplementary Fig. 8c,d). One possibility to
explain the higher impact of CHK1 overexpression during
reprogramming is that CHK1 not only suppresses RS but also
arrests cells in G2, preventing the breakage of stalled forks during
mitosis25. Overall, these data demonstrated the feasibility of
decreasing the levels of reprogramming-induced RS by genetic or
chemical means.
Limiting RS reduces genomic instability in iPSC. We hypo-
thesized that the RS that occurs during reprogramming might
contribute to the genomic instability that has been observed in
iPSC. Therefore, we reasoned that lowering reprogramming-
induced RS could reduce genomic instability in induced plur-
ipotent cells. To test this idea, we ﬁrst analysed whether iPSC
lines generated from Chk1TG MEF presented lower levels of RS.
Indeed, Chk1TG iPSC lines presented lower amounts of gH2AX
than their wt counterparts (Fig. 4a). In addition, we analysed the
level of multi-telomeric signals (MTS), which derive from RS at
telomeric regions, as a direct readout or RS-driven chromosomal
fragility26,27. Again, the average number of MTS/metaphase was
signiﬁcantly lower in Chk1TG iPSC lines compared with wt iPSC
lines (Fig. 4b). Hence, the increased levels of CHK1 provided by
an extra Chk1 allele reduce RS and spontaneous chromosomal
fragility on iPSC. Of note, iPSC lines derived from wt or Chk1TG
MEF were bona ﬁde iPSC as they had silenced the expression of
exogenous transgenes (Supplementary Fig. 1), expressed
pluripotent markers at similar level to that observed in mouse
embryonic stem cells (Supplementary Fig. 10a) and were able to
participate in the formation of chimeric mice (Supplementary
Fig. 10b).
Consistent with the data observed in MEF, human iPSC lines
derived in the presence of exogenously added nucleosides
presented lower amounts of gH2AX and a signiﬁcantly lower
number of MTS/metaphase compared with the levels observed in
untreated iPSC (Fig. 4c,d). Finally, we reasoned that if reported
CNVs found in iPSC derived from RS, nucleoside supplementation
might limit the number of these genome rearrangements. We thus
obtained several human iPSC lines generated in the presence or
absence of nucleoside supplementation during the reprogramming
process. DNA from hiPSC clones was used to evaluate the number
of CNV by array comparative genomic hybridization (aCGH).
Importantly, two independent reprogramming experiments
showed that the average number of de novo CNVs was lower
when reprogramming was done in the presence of nucleoside
supplements (Fig. 4e; Supplementary Fig. 11; Supplementary
Tables 1 and 2). It is noteworthy that most of the de novo CNV
detected in the generated iPSC lines fall into either known fragile
sites, sites of recurrent chromosomal rearrangements or loci that
have been shown to undergo CNV in response to RS-generating
agents such as the ribonucleotide reductase inhibitor hydroxyurea
(HU) or the DNA polymerase inhibitor Aphidicolin28, providing
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Figure 2 | Increased CHK1 levels facilitate reprogramming and reduce RS on iPSC. (a) HTM-mediated quantiﬁcation of gH2AX intensity levels in
wild-type or Chk1TG/TG MEFs 4 days after infection with retroviruses encoding GFP or OSK. Centre lines indicate mean values, whereas squared boxes show
the percentage of outliers. Data are representative of two independent experiments performed in triplicate *Po0.05. (b) Wt, Chk1TG/þ or Chk1TG/TG
MEF were infected with retroviruses encoding OSK and relative reprogramming efﬁciencies were evaluated by counting alkaline-phosphatase-positive
colonies. Data are representative of three independent experiments performed in triplicate in MEF derived from four different embryos. ***Po0.001.
(c) Representative images of the analysis described in b.
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strong support for the notion that the de novo CNV observed
on iPSC are due to RS (Supplementary Tables 1 and 2).
Speciﬁcally, 68% of the 41 CNV shown in Fig. 4e have been
previously linked to RS (12 are known fragile sites and 16 are at
sites that underwent HU and or Aphidicolin-induced CNV).
The nucleoside supplementation conditions deﬁned here did not
affect the pluripotency of hiPSC, as determined by the expression
of pluripotent markers and their capacity to silence exogenous
transgenes (Supplementary Fig. 12). Furthermore, we veriﬁed
that the nucleoside supplementation conditions that lower CNV
numbers on iPSC are not mutagenic. To this end, we exome
sequenced a total of ﬁve untreated and ﬁve nucleosides
treated human iPSC lines and observed a similar number
of point mutations in coding regions regardless of the
treatment (Supplementary Table 3). The number of point
mutations is similar to what had been previously reported for
iPSC, which, as suggested, is likely a reﬂection of mutations
harboured in some of the parental ﬁbroblasts that expanded
during reprogramming2,4,29–31. While not deﬁnitive, these data
are consistent with the rest of the evidences provided in this
manuscript, which reveal that lowering RS during reprogramming
reduces genomic instability in the resultant iPSC.
Discussion
The ﬁndings of genomic instability in iPSC casts doubts on their
safety, due to the potential consequences of these mutations.
Thus, it is necessary to deﬁne culture conditions or protocols
for the generation of iPSC that can reduce genomic instability on
the reprogrammed cells. Here we show, in human and mouse
cells, that reprogramming is associated with increased levels of
RS, which, at least partially, contribute to the genomic instability
of iPSC. Furthermore, we demonstrate that reducing the levels
of RS during the reprogramming process limits the amount of
genomic aberrations and spontaneous chromosomal fragility
found on reprogrammed cells.
Several lines of evidence support our ﬁnding that RS is taking
place during reprogramming. First, we observed elevated levels of
pan-nuclear gH2AX in cells expressing the reprogramming
factors, which we and others have shown in the past is a
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Figure 3 | Nucleoside supplementation decreases RS in cells expressing reprogramming factors. (a) HTM-mediated quantiﬁcation of gH2AX intensity
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hallmark of cells enduring RS16,17,20,32,33. Second, DNA
replication fork speed is lowered by the expression of the
reprogramming factors. Interestingly, the reduced fork speed
that arises during reprogramming occurs in the absence of
fork asymmetry. One possibility to explain this observation is
that reprogramming-induced RS could arise from insufﬁcient
pools of deoxynucleotides, which would lead to reduced fork
speed but symmetrical forks. Accordingly, treatment of
human cells with the ribonucleotide reductase inhibitor HU
reduces fork speed but does not alter fork symmetry
(Supplementary Fig. 13). This would be consistent with
the rescue of RS that we see on nucleoside supplementation, or
with the fact that a large fraction of the CNVs that we have
detected on iPSC were previously reported as induced by HU28. If
reprogramming factors directly alter the expression of enzymes
involved in nucleotide biosynthesis, as previously
shown for oncogenes10, remains to be seen. Finally, functional
inhibition of the ATR/CHK1 kinases, critical effectors of the
RS-response, interferes with cell reprogramming. In summary,
and similar to oncogene-induced RS, our data support that
a reprogramming-induced RS contributes to genomic instability
in iPSC.
The molecular mechanisms behind reprogramming-induced
RS remain obscure, although they would likely be similar to
those proposed in other contexts where RS occurs. For
instance, interference between DNA replication and transcription
machineries, either by the physical presence of reprogramming
factors or by the accumulation of RNA/DNA hybrids due to
the enhanced expression levels, has been shown to drive RS
and genomic rearrangements34. Alternatively, or in addition
to, limiting amounts of nucleotides might not meet the high
proliferation rates that are required for successful
reprogramming35. This later hypothesis would be consistent
with the high percentage of CNV observed on iPSC that were
previously discovered as HU-induced CNV28. The observation
that replication rates per fork are slowed down during
reprogramming, but fork symmetry is not altered, further
supports this view.
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Our work not only documents the existence of reprogramming-
induced RS, but also provides examples of strategies that can be
used to lower this phenomenon: increasing CHK1 levels or the
addition of nucleoside supplements to the culture media. Both
approaches reduce signiﬁcantly the level of DNA damage observed
in iPSC. However, the addition of nucleosides, from a practical
point of view, seems an easy procedure to implement. This simple
practice to reduce genomic instability in iPSC was assessed by
gH2AX levels, telomere fragility and the number of de novo CNV.
Moreover, the conditions deﬁned here did not increase somatic
point mutations. Previous studies have reported the presence of
CNV on pluripotent cells (either ESC or iPSC) maintained during
prolonged time in culture3,7,36. We speculate that nucleoside
supplementation might also serve to diminish the severity of these
effects. Along these lines, it is interesting to note that the
supplement we have used in this manuscript is a nucleoside
solution that is commercialized for the growth of ESC cultures. Of
note, the conditions deﬁned in this manuscript only partially
reduce the genomic instability of iPSC, which can also derive from
other known sources of DNA damage such as reactive oxygen
species5. Nevertheless, these initial studies provide proof-of-
concept for the design of cell culture practices that can diminish
DNA damage during reprogramming. Future research in this area
will probably further reduce this unwanted off-target effect of the
reprogramming process.
Reports documenting the presence of genomic instability on
iPSC have raised concerns regarding their clinical use. Our work
here illustrates that reprogramming-induced RS contributes to
the genomic instability of iPSC, and reveals that the addition of
nucleosides to the reprogramming medium provides a simple
approach to reduce the number of genomic rearrangements that
are generated during the reprogramming of somatic cells.
Methods
Cell culture. dFib-indOSK ﬁbroblasts-like cells18, 293T cells (ATCC, CRL-3216),
PGP2 (gift from George Church, Harvard University) and BJ human ﬁbroblasts
(ATCC, CRL-2522) were grown in DMEM (Invitrogen), 10%FBS and 0.1mM
non-essential amino acids. MEFs were obtained from 13.5 embryos by standard
methods and cultured in DMEM, 15%FBS and 0.1mM non-essential amino acids
in low-oxygen conditions. The hESC line H9 (WA09), obtained from WiCell
Research Institute, as well as the different hiPSC lines generated were cultured in
Geltrex (Invitrogen) with mTeSR1 media (Stem Cell Technologies). miPSC clones
were cultured on a feeder layer of inactivated MEFs with DMEM (high glucose)
supplemented with 15% knockout serum replacement (Invitrogen), LIF
(1,000Uml 1), 0.1mM non-essential amino acids, 1% glutamax and 55 mM
b-mercaptoethanol.
Plasmid construction. For the construction of pMX-CHK1, the coding sequences
of Chk1 were ampliﬁed by PCR from human complementary DNA. PCR products
were digested with EcoRI and sub-cloned into an EcoRI-linearized pMX retroviral
vector. The ﬁnal construct was sequenced to rule out the presence of mutations.
Retroviral production. Moloney-based retroviral pMX-derived vectors were
co-transfected with packaging vectors in 293T cells using Lipofectamine 2000
(Invitrogen) to generate viral particles as previously described18.
Human and mouse iPSC generation. Primary MEF (passage 2–4) were incubated
with retroviral supernatants expressing the reprogramming factors up to four times
(one infection every 12 h) after which the regular media was replaced by miPSC
culture media (see above). Cultures were maintained until ES-cell-like colonies
arose. Clones of ES-cell-like cells were then picked and expanded on feeder
ﬁbroblasts. To generate hiPSCs, BJ ﬁbroblasts were infected with retroviral
supernatants by infection of the cells at 1,850 r.p.m. for 1 h at room temperature in
the presence of polybrene (4mgml 1). After two viral infections, cells were
trypsinized and plated on top of irradiated MEFs. One day later, cells were switched
to a media containing DMEM/F12 (Invitrogen), 20% knockout serum replacement,
0.1mM non-essential amino acids, 1% glutamax, 55 mM b-mercaptoethanol and
10 ngml 1 bFGF (Mylteni Biotec). In the case of dFib-indOSK ﬁbroblasts-like cells,
cells were also infected with the corresponding retroviral supernatants and the
media was supplemented with doxycycline to induce the expression of OSK and
promote reprogramming as described18. Where indicated, reprogramming cells
were incubated with nucleosides (Embryomax ES-cell-qualiﬁed nucleosides,
100 solution, Millipore), which were added daily. To evaluate reprogramming
efﬁciencies, we plated the same number of infected BJ ﬁbroblasts or dFib-indOSK
ﬁbroblasts-like cells on irradiated MEFs and the relative percentage of Nanogþ
colonies compared with the colonies observed in the control was scored. Nanog
detection was performed as described18. Reprogramming efﬁciency was
additionally scored by evaluating the relative percentage of GFPþ (resulting from
the endogenous reactivation of the OCT4 promoter) and RFP (resulting from
silencing of exogenous retroviral sequences encoding for red ﬂuorescent protein
(RFP)) colonies obtained from dFib-indOSK-reprogrammed cells.
RNA isolation and real-time PCR. Total RNA was isolated using the Absolutely
RNA Microprep Kit (Stratagene) according to manufacturer’s recommendations.
Complementary DNA was synthesized using the SuperScript II Reverse
Transcriptase kit for RT–PCR (Invitrogen). Real-time PCR was performed using
the SYBR-Greener qPCR Supermix (Invitrogen) in the Cycler Real-Time PCR
System (BioRad). GAPDH expression level was used to normalize values of gene
expression. Data are shown as fold change relative to the sample control and at
least two independent experiments in triplicate were performed. Sequences of the
primers used in this work are shown in Supplementary Table 4.
Western blot analysis. Cell pellets were lysed in 50mM Tris pH 7.9/8M
urea/1%Chaps and incubated with shaking at 4 C for at least 30min. About 25 mg
of supernatants were run and transferred for gH2AX detection by using a mouse
monoclonal antibody against gH2AX (1:1,000, Upstate 05-636). Tubulin was used
as control loading (1:10,000, Sigma).
High-throughput microscopy. BJ ﬁbroblasts, MEF, iPSC or dFib-indOSK
ﬁbroblast-like cells were plated on mCLEAR bottom 96-well plates (Greiner
Bio-One). One day later, cells were untreated, infected by spinfection twice and/or
incubated with nucleosides or doxycline as indicated. gH2AX staining was
performed using standard procedures as described24 and images were
automatically acquired in an Opera High-Content Screening System (Perkin
Elmer). Each condition was performed in triplicate and at least 25 different ﬁelds
per well at a  20 magniﬁcation were taken. Images were segmented using a DAPI
(40 ,6-diamidino-2-phenylindole) staining to generate nuclear masks from which
the mean gH2AX signal was calculated.
Array comparative genomic hybridization. For the detection of CNV, genomic
DNA isolated from iPSC and the original human ﬁbroblasts was hybridized in
SurePrint G3 Human High Resolution 1X1M Microarrays (CNV) (Agilent
Technologies) following manufacturer’s instructions. CNV regions in each sample
were identiﬁed using a Reversible Jump Hidden Markov Model implemented in the
software RJaCGH37 requiring an average posterior probability of the probes40.75.
Next, calls that did not fulﬁl the following criterion were ﬁltered out: an average
log2value of the region equal to the median±1.5 s.d. of all log2values of the chip.
CNVs were also identiﬁed using the aberration detection method (ADM-2: 6,5
value) algorithm suggested by Agilent Technologies. We established a log2 ratio
(Cy5/Cy3) threshold of ±0,25 and the concurrence of at least four consecutive
probes with differential signal intensity for consideration as a CNV. All iPSC lines
were grown for equal number of days for a total of six passages before collecting
samples for DNA isolation.
DNA combing. Human BJ neonatal foreskin ﬁbroblasts (5 105) were infected
with retroviruses encoding OSKM and media supplemented or not with
nucleosides. After 72 h, cells were pulsed with IdU (100mM) for 15min at 37C
and subsequently with CldU (100 mM) for 30min at 37C. About 4.5 104 cells
were washed and resuspended in cold PBS and mixed in 1:1 ratio with PBS con-
taining 1% low melting agarose, transferred to casting mould and allowed to
solidify at 21 C. Plugs were incubated in 0.5ml of proteinase K buffer in a 12-ml
round-bottom tube at 50 C for 3 days, with buffer replaces after each 24-h period.
Plugs were washed ﬁve times with 10ml of TE at 21 C and incubated in dark at
21 C for 30min in 100 ml of TE supplemented with 1.5 ml of YOYO-1. After four
additional washes with TE, plugs were incubated with MES pH 5.7 for 20min at
70 C in the dark. About 3U of beta-agarase (NEB) was added and further incu-
bated overnight at 42 C. DNA was combed onto silanized coverslip and subse-
quently heated for 2 h at 60 C. Coverslips were dounced in 70, 90 and 100% EtOH
in coplin jars, incubated for 25min in 1M NaOH and then incubated with anti-
CldU (AbCys SA), anti-IdU (Becton Dickinson) and anti-ssDNA (Chemicon) in a
humid chamber at 37 C. Coverslips were washed ﬁve times with PBS/Tween and
incubated with secondary antibodies (Molecular Probes) for 30min at 37 C. After
washing with PBS, Prolong Gold Antifade mounting reagent was added to the
coverslips and incubated at 21 C for 2 h. Cells were imaged on Zeiss Observer
microscope at  63 objective. Fork asymmetry was deﬁned as the ratio between the
longest to the shortest track.
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Multi-telomeric signals. MTS were detected on metaphases after ﬂuorescent
in situ hybridization with a telomeric probe as previously described38. At least 50
metaphases per sample were scored for MTS by superimposing the telomere image
on the DAPI chromosomes image.
Exome sequencing. Enrichment of coding exons was done using Truseq exome
capture following manufacturer’s instructions. Libraries (Trueseq V2) were
sequenced on a HiSeq sequencer with 101 2-paired end reads. Library generation,
exome capture and sequencing for control and nucleoside-treated iPSC were car-
ried out simultaneously.
Identiﬁcation of point mutations. Fastq ﬁles were aligned to the human reference
(hg19) using Novoalign. Mapped reads were realigned, quality scores were reca-
librated using GATK39 and PCR artifacts removed using Picard’s MarkDuplicates
(http://picard.sourceforge.net). Variants were called using GATK’s uniﬁed
genotyper39.
Animal research. Chk1 transgenic mice were kept under standard conditions at
speciﬁc-pathogen-free facility of the Spanish National Cancer Centre in a mixed
background24. All mouse work was performed in accordance with the Guidelines
for Human Endpoints for Animals Used in Biomedical Research, and under the
supervision of the Ethics Committee for Animal Research of the ‘Instituto de Salud
Carlos III’.
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